These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11182562)

  • 21. Preparation and in vivo evaluation of linkers for 211At labeling of humanized anti-Tac.
    Yordanov AT; Garmestani K; Zhang M; Zhang Z; Yao Z; Phillips KE; Herring B; Horak E; Beitzel MP; Schwarz UP; Gansow OA; Plascjak PS; Eckelman WC; Waldmann TA; Brechbiel MW
    Nucl Med Biol; 2001 Oct; 28(7):845-56. PubMed ID: 11578907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiopharmaceutical chemistry of targeted radiotherapeutics, Part 2: radiolytic effects of 211At alpha-particles influence N-succinimidyl 3-211AT-astatobenzoate synthesis.
    Pozzi OR; Zalutsky MR
    J Nucl Med; 2005 Aug; 46(8):1393-400. PubMed ID: 16085599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and evaluation of 211At labelled antineoplastic antibodies.
    Walte A; Sriyapureddy SS; Korkmaz Z; Krull D; Bolte O; Hofmann M; Meyer GJ; Knapp WH
    J Pharm Pharm Sci; 2007; 10(2):277s-285s. PubMed ID: 17718931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiobromination of humanized anti-HER2 monoclonal antibody trastuzumab using N-succinimidyl 5-bromo-3-pyridinecarboxylate, a potential label for immunoPET.
    Mume E; Orlova A; Malmström PU; Lundqvist H; Sjöberg S; Tolmachev V
    Nucl Med Biol; 2005 Aug; 32(6):613-22. PubMed ID: 16026708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective targeting of tumour neovasculature by a radiohalogenated human antibody fragment specific for the ED-B domain of fibronectin.
    Demartis S; Tarli L; Borsi L; Zardi L; Neri D
    Eur J Nucl Med; 2001 Apr; 28(4):534-9. PubMed ID: 11357506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[211At]astato-3-pyridinecarboxylate.
    Reist CJ; Foulon CF; Alston K; Bigner DD; Zalutsky MR
    Nucl Med Biol; 1999 May; 26(4):405-11. PubMed ID: 10382844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (211)At-labeled and biotinylated effector molecules for pretargeted radioimmunotherapy using poly-L- and poly-D-Lysine as multicarriers.
    Lindegren S; Karlsson B; Jacobsson L; Andersson H; Hultborn R; Skarnemark G
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3873S-9S. PubMed ID: 14506185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and in vivo evaluation of a novel stabilized linker for 211At labeling of protein.
    Talanov VS; Garmestani K; Regino CA; Milenic DE; Plascjak PS; Waldmann TA; Brechbiel MW
    Nucl Med Biol; 2006 May; 33(4):469-80. PubMed ID: 16720238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Labeling proteins at high specific activity using N-succinimidyl 4-[18F](fluoromethyl) benzoate.
    Lang L; Eckelman WC
    Appl Radiat Isot; 1997 Feb; 48(2):169-73. PubMed ID: 9219343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astatinated trastuzumab, a putative agent for radionuclide immunotherapy of ErbB2-expressing tumours.
    Persson MI; Gedda L; Jensen HJ; Lundqvist H; Malmström PU; Tolmachev V
    Oncol Rep; 2006 Mar; 15(3):673-80. PubMed ID: 16465429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biodistribution of 211At labeled HER-2 binding affibody molecules in mice.
    Steffen AC; Almqvist Y; Chyan MK; Lundqvist H; Tolmachev V; Wilbur DS; Carlsson J
    Oncol Rep; 2007 May; 17(5):1141-7. PubMed ID: 17390057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of tumor mass and antigenic nature on the biodistribution of labeled monoclonal antibodies in mice.
    Watanabe Y; Endo K; Koizumi M; Kawamura Y; Saga T; Sakahara H; Kuroki M; Matsuoka Y; Konishi J
    Cancer Res; 1989 Jun; 49(11):2884-9. PubMed ID: 2470499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate: synthesis and potential utility for the radioiodination of monoclonal antibodies.
    Garg PK; Garg S; Zalutsky MR
    Nucl Med Biol; 1993 May; 20(4):379-87. PubMed ID: 8504279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.
    Andersson H; Lindegren S; Back T; Jacobsson L; Leser G; Horvath G
    Anticancer Res; 2000; 20(1A):459-62. PubMed ID: 10769696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiotoxicity of systemically administered 211At-labeled human/mouse chimeric monoclonal antibody: a long-term survival study with histologic analysis.
    McLendon RE; Archer GE; Larsen RH; Akabani G; Bigner DD; Zalutsky MR
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):491-9. PubMed ID: 10487576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astatination of nanoparticles containing silver as possible carriers of 211At.
    Kucka J; Hrubý M; Konák C; Kozempel J; Lebeda O
    Appl Radiat Isot; 2006 Feb; 64(2):201-6. PubMed ID: 16154358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bifunctional aryliodonium salts for highly efficient radioiodination and astatination of antibodies.
    Guérard F; Navarro L; Lee YS; Roumesy A; Alliot C; Chérel M; Brechbiel MW; Gestin JF
    Bioorg Med Chem; 2017 Nov; 25(21):5975-5980. PubMed ID: 28964629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid and high-yielding cysteine labelling of peptides with N-succinimidyl 4-[18F]fluorobenzoate.
    Abad S; Nolis P; Gispert JD; Spengler J; Albericio F; Rojas S; Herance JR
    Chem Commun (Camb); 2012 Jun; 48(49):6118-20. PubMed ID: 22576415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-succinimidyl 3-[(131)I]iodo-4-phosphonomethylbenzoate ([(131)I]SIPMB), a negatively charged substituent-bearing acylation agent for the radioiodination of peptides and mAbs.
    Shankar S; Vaidyanathan G; Affleck D; Welsh PC; Zalutsky MR
    Bioconjug Chem; 2003; 14(2):331-41. PubMed ID: 12643743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the therapeutic efficacy of 211At- and 131I-labelled monoclonal antibody MOv18 in nude mice with intraperitoneal growth of human ovarian cancer.
    Andersson H; Palm S; Lindegren S; Bäck T; Jacobsson L; Leser G; Horvath G
    Anticancer Res; 2001; 21(1A):409-12. PubMed ID: 11299770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.